Abstract
Autoantibodies to various cytokines have been reported in normal individuals and in patients with various infectious and immunoinflammatory disorders, and similar antibodies (Ab) may be induced in patients receiving human recombinant cytokines. The clinical relevance of these Ab is often difficult to evaluate. Not only are in vitro neutralizing cytokine Ab not necessarily neutralizing in vivo, but assays for binding and neutralizing Ab to cytokines are often difficult to interpret. For example, denaturation of immobilized cytokines in immunoblotting techniques and immunometric assays may leave Ab to the native forms of the mediators unrecognized. On the other hand, Ab may bind nonspecifically and/or with biologically irrelevant low affinities, leading to erroneous interpretations. This article describes in detail the use of radioimmunoassays that we have optimized and used successfully for the detection of high-affinity (auto)Ab to IL-1α, IL-6, GM-CSF, and IFNα.
Similar content being viewed by others
References
Trown, P. W., Kramer, M. J., Dennin, R. A., Connell, E. V., Palleroni, A. V., Quesada, J., et al (1983) Antibodies to human leucocyte interferons in cancer patients. Lancet. 1, 81–87.
Panem, S. (1984) Antibodies to interferon in man. Interferon 2, 175–183.
Bost, K. L., Hahn, B. H., Saag, M. S., Shaw, G. M., Weigent, D. A., and Blalock, J. E. (1988) Individuals infected with HIV possess antibodies against IL-2. Immunology 65, 611–615.
Svenson, M., Poulsen, L. K., Fomsgaard, A., and Bendtzen, K. (1989) IgG autoantibodies against interleukin 1α in sera of normal individuals. Scand. J. Immunol. 29, 489–492.
Fomsgaard, A., Svenson, M., and Bendtzen, K. (1989) Auto-antibodies to tumour necrosis factor a in healthy humans and patients with inflammatory diseases and Gram-negative bacterial infections. Scand. J. Immunol. 30, 219–223.
Prümmer, O., Seyfarth, C., Scherbaum, A., Drees, N., and Porzsolt, F. (1989) Interferon-a antibodies in autoimmune diseases. J. Interferon Res. 9, Suppl. 1, S67-S74.
Suzuki, H., Akama, T., Okane, M., Kono, I., Matsui, Y., Yamane, K., et al (1989) Interleukin-1-inhibitory IgG in sera from some patients with rheumatoid arthritis. Arthritis Rheum. 32, 1528–1538.
Jeffes, E. W. B., Ininns, E. K., Schmitz, K. L., Yamamoto, R. S., Dett, C. A., and Granger, G. A. (1989) The presence of antibodies to lymphotoxin and tumor necrosis factor in normal serum. Arthritis Rheum. 32, 1148–1152.
Bendtzen, K., Svenson, M., Jønsson, V., and Hippe, E. (1990) Autoantibodies to cytokines—friends of foes? Immunol. Today 11, 167–169.
Caruso, A., Bonfanti, C., Colombrita, D., de Francesco, M., de Rango, C., Foresti, I., et al (1990) Natural antibodies to IFN-γ in man and their increase during viral infection. J. Immunol. 144, 685–690.
Suzuki, H., Kamimura, J., Ayabe, T., and Kashiwagi, H. (1990) Demonstration of neutralizing autoantibodies against IL-1α in sera from patients with rheumatoid arthritis. J. Immunol. 145, 2140–2146.
Ross, C., Hansen, M. B., Schyberg, T., and Berg, K. (1990) Autoantibodies to crude human leucocyte interferon (IFN), native human IFN, recombinant human IFN-α2b and human IFN-γ in healthy blood donors. Clin. Exp. Immunol. 82, 57–62.
Pedersen, M., Permin, H., Bindslev-Jensen, C., Bendtzen, K., and Norn, S. (1991) Cytokine-induced histamine release from basophils of AIDS patients. Interaction between cytokines and specific IgE antibodies. Allergy 46, 129–134.
Hansen, M. B., Svenson, M., Diamant, M., and Bendtzen, K. (1991) Anti-interleukin-6 antibodies in normal human serum. Scand. J. Immunol. 33, 777–781.
Mae, N., Liberato, D. J., Chizzonite, R. and Satoh, H. (1991) Identification of high-affinity anti-IL-1α autoantibodies in normal human serum as an interfering substance in a sensitive enzyme-linked immunosorbent assay for IL-1α. Lymphokine Cytokine Res. 10, 61–68.
Ikeda, Y., Toda, G., Hashimoto, N., Umeda, N., Miyake, K., Yamanaka, M., et al (1991) Naturally occurring anti-interferon-α2a antibodies in patients with acute viral hepatitis. Clin. Exp. Immunol. 85, 80–84.
Saurat, J.-H., Schifferli, J., Steiger, G., Dayer, J.-M., and Didierjean, L. (1991) Anti-interleukin-1α autoantibodies in humans: Characterization, isotype distribution, and receptor-binding inhibition—Higher frequency in Schnitzler’s syndrome (urticaria and macroglobulinemia). J. Allergy Clin. Immunol. 88, 244–256.
Suzuki, H., Ayabe, T., Kamimura, J., and Kashiwagi, H. (1991) Anti-IL-1α autoantibodies in patients with rheumatic diseases and in healthy subjects. Clin. Exp. Immunol. 85, 407–412.
Sunder-Plassmann, G., Sedlacek, P. L., Sunder-Plassmann, R., Derfler, K., Swoboda, K., Fabrizii, V., et al (1991) Anti-interleukin-1α autoantibodies in hemodialysis patients. Kidney Int. 40, 787–791.
Galley, P., Mach, J.-P., and Carrel, S. (1991) Characterization and detection of naturally occurring antibodies against IL-1α and IL-1β in normal human plasma. Eur. Cytokine Netw. 2, 329–338.
Viani, E., Flamminio, G., Caruso, A., Foresti, I., de Francesco, M., Pollara, P., et al (1991) Purification of natural human IFN-γ antibodies. Immunol. Lett. 30, 53–58.
Prümmer, O., Frickhofen, N., Digel, W., Heimpel, H. and Porzsolt, F. (1991) Spontaneous interferon-α antibedies in a patient with pure red cell aplasia and recurrent cutaneous carcinomas. Ann. Hematol. 62, 76–80.
Takemura, H., Suzuki, H., Yoshizaki, K., Ogata, A., Yuhara, T., Akama, T., et al (1992) Anti-interleukin-6 autoantibodies in rheumatic diseases. Increased frequency in the sera of patients with systemic sclerosis. Arthritis Rheum. 35, 940–943.
May, L. T., Viguet, H., Kenney, J. S., Ida, N., Allison, A. C., and Sehgal, P. B. (1992) High levels of “complexed” interleukin-6 in human blood. J. Biol. Chem. 267, 19698–19704.
Peichl, P., Ceska, M., Broell, H., Effenberger, F., and Lindley, I. J. D. (1992) Human neutrophil activating peptide/interleukin 8 acts as an autoantigen in rheumatoid arthritis. Ann. Rheum. Dis. 51, 19–22.
Sylvester, I., Yoshimura, T., Sticherling, M., Schröder, J. M., Ceska, M., Peichl, P., et al (1992) Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum. J. Clin. Invest. 90, 471–481.
Reitamo, S., Remitz, A., Varga, J., Ceska, M., Effenberger, F., Jimenez, S., et al (1993) Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders. Arch. Dermatol. 129, 189–193.
Turano, A. and Caruso, A. (1993) The role of human autoantibodies against gamma-interferon. J. Antimicrob. Chemother. 32, Suppl. A, 99–105.
Heilig, B., Fiehn, C., Brockhaus, M., Gallati, H., Pezzutto, A., and Hunstein, W. (1993) Evaluation of soluble tumor necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematodes, progressive systemic sclerosis, and mixed connective tissue disease. J. Clin. Immunol. 13, 321–328.
Tiberio, L., Caruso, A., Pozzi, A., Rivoltini, L., Morelli, D., Monti, E., et al (1993) The detection and biological activity of human antibodies to IL-2 in normal donors. Scand. J. Immunol. 38, 472–476.
Sylvester, I., Suffredini, A. F., Boujoukos, A. J., Martich, G. D., Danner, R. L., Yoshimura, T., et al (1993) Neutrophil attractant protein-1 and monocyte chemoattractant protein-1 in human serum. Effects of intravenous lipopolysaccharide on free attractants, specific IgG autoantibodies and immune complexes. J. Immunol. 151, 3292–3298.
Hansen, M. B., Svenson, M., Abell, K., Varming, K., Nielsen, H. P., Bertelsen, A., et al (1994) Sex- and age-dependency of IgG auto-antibodies against IL-1α in healthy humans. Eur. J. Clin. Invest. 24, 212–218.
Suzuki, H., Takemura, H., Yoshizaki, K., Koishihara, Y., Ohsugi, Y., Okano, A., et al (1994) IL-6-anti-IL-6 autoantibody complexes with IL-6 activity in sera from some patients with systemic sclerosis. J. Immunol. 152, 935–942.
Satoh, H., Chizzonite, R., Ostrowski, C., Ni-Wu, G., Kim, H., Fayer, B., et al (1994) Characterization of anti-IL-1α autoantibodies in the sera from healthy humans. Immunopharmacol. 27, 107–118.
Prümmer, O., Bunjes, D., Wiesneth, M., Arnold, R., Porzsolt, F., and Heimpel, H. (1994) High-titre interferon-α antibodies in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant. 14, 483–486.
Kearney, J. F. (1994) Formation of autoantibodies, including anti-cytokine antibodies, is a hallmark of the immune response of early B cells. J. Interferon Res. 14, 151–152.
Bendtzen, K. (1994) Cytokines and natural regulators of cytokines. Immunol. Lett. 43, 111–123.
Bendtzen, K., Hansen, M. B., Ross, C., Poulsen, L. K. and Svenson, M. (1995) Cytokines and autoantibodies to cytokines. Stem Cells 13, 206–222.
Itoh, Y., Okanoue, T., Sakamoto, S., Nishioji, K., Kashima, K., and Ohmoto, Y. (1995) Serum autoantibody against interleukin-1α is unrelated to the etiology or activity of liver disease but can be raised by interferon treatment. Am. J. Gastroenterol. 90, 777–782.
Trotter, J. L., Damico, C. A., Trotter, A. L., Collins, K. G., and Cross, A. H. (1995) Interleukin-2 binding proteins in sera from normal subjects and multiple sclerosis patients. Neurology 45, 1971–1974.
Dicou, E., Perrot, S., Menkes, C. J., Masson, C., and Nerriere, V. (1996) Nerve growth factor (NGF) autoantibodies and NGF in the synovial fluid: Implications in spondylarthropathies. Autoimmunity 24, 1–9.
Laricchia-Robbio, L., Moscato, S., Genua, A., Liberati, A. M., and Revoltella, R. P. (1997) Naturally occurring and therapy-induced antibodies to human granulocyte colony-stimulating factor (G-CSF) in human serum. J. Cell. Physiol. 173, 219–226.
Svenson, M., Hansen, M. B., Ross, C., Diamant, M., Rieneck, K., Nielsen, H., et al (1998) Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations. Blood 91, 2054–2061.
Bendtzen, K., Hansen, M. B., Ross, C., and Svenson, M. (1998) High-avidity autoantibodies to cytokines. Immunol. Today 19, 209–211.
Garrone, P., Djossou, O., Fossiez, F., Reyes, J., Ait-Yahia, S., Maat, C., et al (1996) Generation and characterization of a human monoclonal autoantibody that acts as a high affinity interleukin-1α specific inhibitor. Mol. Immunol. 33, 649–658.
Vallbracht, A., Treuner, J., Flehmig, B., Joester, K. E., and Niethammer, D. (1981) Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon. Nature 289, 496–497.
Gribben, J. G., Devereux, S., Thomas, N. S. B., Keim, M., Jones, H. M., Goldstone, A. H., et al (1990) Development of antibodies to unprotected glycoylation sites on recombinant human GM-CSF. Lancet 335, 434–437.
Steinmann, G. G., Rosenkaimer, F., and Leitz, G. (1993) Clinical experiences with interferon-α and interferon-γ. Int. Rev. Exp. Pathol. 34, Pt B, 193–207.
Giannelli, G., Antonelli, G., Fera, G., Del Vecchio, S., Riva, E., Broccia, C., et al (1994) Biological and clinical significance of neutralizing and binding antibodies to interferon-α (IFN-α) during therapy for chronic hepatitis C. Clin. Exp. Immunol. 97, 4–9.
von Wussow, P., Hehlmann, R., Hochhaus, T., Jakschies, D., Nolte, K. U., Prümmer, O., Ansari, H., et al (1994) Roferon (rIFN-α2a) is more immunogenic than intron A (rIFN-α2b) in patients with chronic myelogenous leukemia. J. Interferon Res. 14, 217–219.
Hansen, M. B., Svenson, M., and Bendtzen, K. (1991) Human anti-interleukin 1α antibodies. Immunol. Lett. 30, 133–140.
Svenson, M., Hansen, M. B., Kayser, L., Rasmussen, K., Reimert, C. M., and Bendtzen, K. (1992) Effects of human anti-IL-1α autoantibodies on receptor binding and biological activities of IL-1. Cytokine 4, 125–133.
Toyoda, M., Zhang, X., Petrosian, A., Galera, O. A., Wang, S.-J., and Jordan, S.C. (1994) Modulation of immunoglobulin production and cytokine mRNA expression in peripheral blood mononuclear cells by intravenous immunoglobulin. J. Clin. Immunol. 14, 178–189.
Ross, C., Svenson, M., Hansen, M. B., Vejlsgaard, G. L., and Bendtzen, K. (1995) High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG. J. Clin. Invest. 95, 1974–1978.
Klein, B. and Brailly, H. (1995) Cytokine-binding proteins: stimulating antagonists. Immunol. Today 16, 216–220.
Bendtzen, K., Hansen, M. B., Ross, C., and Svenson, M. (1996) In Autoantibodies (Peter, J. B., and Shoenfeld, Y., eds.), Elsevier Science B.V. Amsterdam, pp. 209–216.
Svenson, M., Hansen, M. B., and Bendtzen, K. (1993) Binding of cytokines to pharmaceutically prepared human immunoglobulin. J. Clin. Invest. 92, 2533–2539.
Svenson, M. and Herbrink, P. (1997) Measurement of cytokine antibodies. Test development. Biotherapy 10, 87–92.
Greenbaum, C. J., Palmer, J. P., Kuglin, B., and Kolb, H. (1992) Insulin autoantibodies measured by radio-immunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurements. J. Clin. Endocrinol. Metab. 74, 1040–1044.
Hansen, M. B., Svenson, M., Diamant, M., and Bendtzen, K. (1993) High-affinity IgG autoantibodies to IL-6 in sera of normal individuals are competitive inhibitors of IL-6 in vitro. Cytokine 5, 72–80.
Sedmak, J. J. and Grossberg, S. E. (1989) High levels of circulating neutralizing antibody in normal animals to recombinant mouse interferon-β produced in yeast. J. Interferon Res. 9, Suppl. 1, S61-S65.
Hansen, M. B., Svenson, M., Diamant, M., Ross, C., and Bendtzen, K. (1995) Interleukin-6 (IL-6) autoantibodies and blood IL-6 measurements. Blood 85, 1145.
Svenson, M., Hansen, M. B., and Bendtzen, K. (1990) Distribution and characterization of autoantibodies to interleukin 1α in normal human sera. Scand. J. Immunol. 32, 695–701.
Gammeltoft, S. (1990) In peptide hormone action. A practical approach (Siddle, K., and Hutton, J. C., eds.), Oxford University Press, Oxford, pp. 1–40.
Chizzonite, R., Truitt, T., Podlaski, F. J., Wolitzky, A. G., Quinn, P. M., Nunes, P., et al (1991) IL-12: monoclonal antibodies specific for the 40-kDa subunit block receptor binding and biologic activity on activated human lymphoblasts. J. Immunol. 147, 1548–1556.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bendtzen, K., Hansen, M.B., Ross, C. et al. Detection of autoantibodies to cytokines. Mol Biotechnol 14, 251–261 (2000). https://doi.org/10.1385/MB:14:3:251
Issue Date:
DOI: https://doi.org/10.1385/MB:14:3:251